3 suspended. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Suspended 3 |
Follow Marijuana Abuse: new trials by email Literature Review of Marijuana Abuse trials Research Report on Marijuana Abuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeated Administration of Cannabis Varying in THC and CBD Cannabis - Cannabis | Phase 2 | Suspended | New York State Psychiatric Institute | 100 | 2026-10-01 | 2026-09-01 |
| Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment THC ~2.5%, THC ~5%, THC ~10% - Migraine, Cannabis | Phase 2 | Suspended | University of California, San Diego | 20 | 2023-02-15 | 2026-03-16 |
| Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans Active Cannabis, Placebo Cannabis - Cannabis, Pain | Phase 2 | Suspended | New York State Psychiatric Institute | 16 | 2021-08-01 | 2026-09-24 |
Hyperalgesia (1) · Migraine Disorders (1) · Pain (1)
Chemically-Induced Disorders (3) · Mental Disorders (3) · Substance-Related Disorders (3) · Nervous System Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Somatosensory Disorders (1)
nabiximols (2) · Dronabinol (1) · THC 5 (1) · salicylhydroxamic acid (1)
New York State Psychiatric Institute (2) · University of California, San Diego (1)
United States (3)
R21DA050752 (1)